Keyphrases
Radiotherapy
58%
5-fluorouracil (5-FU)
43%
Chemotherapy
37%
Medical Center
33%
Northern Israel
31%
Antiemetics
31%
Metastatic Renal Cell Carcinoma (mRCC)
31%
Prostate Cancer
29%
Prostate
28%
Radiation Therapy
28%
Breast Cancer
28%
Vinblastine
27%
Tumor
24%
Metoclopramide
23%
High Dose
23%
Oncology Center
23%
Resection
22%
Non-Hodgkin Lymphoma
18%
Renal Cell Carcinoma
17%
Prostatic Carcinoma
17%
Rectum
17%
Combination Chemotherapy
17%
Interleukin-2
17%
Metastasis
17%
Lymphoma
17%
Cyclophosphamide
16%
Methotrexate
16%
Prostate-specific Antigen
16%
Superoxide Dismutase
15%
Prostate Radiotherapy
15%
Parotid Gland
15%
Rare Cancer Network
15%
Primary Lymphoma
15%
Recombinant interleukin-2
15%
Second-line Chemotherapy
15%
Cis-platinum
15%
Systemic Relapse
15%
Biodegradable Balloon
15%
Prostatic Cancer
15%
Center Experience
15%
Early Breast Cancer
15%
Aminoglutethimide
15%
Immunochemotherapy
14%
Irradiation
14%
Breast Carcinoma
14%
Complete Remission
13%
Lung Metastasis
13%
Locoregional Recurrence
13%
Total Dose
13%
Complete Response
12%
Medicine and Dentistry
Radiation Therapy
100%
Diseases
65%
Breast Cancer
48%
Prostate Cancer
42%
Neoplasm
40%
Retrospective Study
37%
Oncology
28%
Metastatic Carcinoma
27%
Malignant Neoplasm
23%
Kidney Metastasis
23%
Non-Hodgkin Lymphoma
23%
Implant
23%
Recurrent Disease
22%
Vinblastine
20%
Cancer
19%
Breast Carcinoma
18%
Thoracic Wall
18%
Fluorouracil
17%
Interleukin 2
17%
Doxorubicin
16%
Superoxide Dismutase
15%
Parotid Gland
15%
Adenocarcinoma
14%
Side Effect
13%
Lung
13%
Prednisone
11%
Lung Metastasis
11%
Computer Assisted Tomography
11%
External Beam Radiotherapy
10%
Lymph Node
10%
Fibrosis
9%
Clear Cell Renal Cell Carcinoma
9%
Intensity Modulated Radiation Therapy
9%
Urinary System
9%
Prostate Carcinoma
9%
Second Cancer
9%
Interferon
9%
Leukopenia
9%
Pelvic Radiotherapy
8%
Hyperbaric Medicine
7%
Iodine 125
7%
Clinical Stage
7%
Clinical Feature
7%
Low Drug Dose
7%
Prostate Specific Antigen
7%
Immunoglobulin
7%
Electron Intraoperative Radiotherapy
7%
Quadrantectomy
7%
Cerebral Hemorrhage
7%
Legionella
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
71%
Diseases
63%
Breast Cancer
32%
Kidney Metastasis
31%
Prostate Cancer
31%
Fluorouracil
31%
Antiemetic Agent
29%
Side Effect
27%
Vinblastine
26%
Retrospective Study
25%
Interleukin 2
25%
Neoplasm
24%
Metoclopramide
23%
Nonhodgkin Lymphoma
23%
Remission
20%
Breast Carcinoma
20%
Cisplatin
19%
Prostate Specific Antigen
18%
Recombinant Interleukin 2
15%
Superoxide Dismutase
15%
Transitional Cell Carcinoma
15%
Dexamethasone
15%
Aminoglutethimide
15%
Cyclophosphamide
13%
Doxorubicin
12%
Fibroblast Growth Factor Receptor
10%
Methotrexate
10%
Diarrhea
10%
Hormone Cancer Therapy
10%
Fibrosis
9%
Renal Cell Carcinoma
9%
Prostate Carcinoma
9%
Interferon
9%
Malignant Neoplasm
9%
Leukopenia
9%
Androgen
7%
CD8 Antigen
7%
Recombinant Interferon
7%
Iodine-125
7%
Cancer Chemotherapy
7%
Implant
7%
Tamoxifen
7%
Docetaxel
7%
Immunoglobulin
7%
Abiraterone Acetate
7%
Cabazitaxel
7%
Castration Resistant Prostate Cancer
7%
Immunotherapy
7%
Mitomycin
7%
Nasopharynx Carcinoma
7%